TOX3 and breast neoplasm: Although more mechanical studies are required to determine the regulation of TOX3 expression by epigenetic modifiers, our findings on the upregulation of TOX3 by cytosine methylation raise the possibility of new epigenetic biomarkers for prognosis of aggressive ER positive breast tumors.